Skip to the page

Data / Drug companies / El-Peptido (Shanghai) Biopharmaceutical Co., Ltd

El-Peptido (Shanghai) Biopharmaceutical Co., Ltd: 26 products in the FDA NDC directory, labeler code 87370

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

El-Peptido (Shanghai) Biopharmaceutical Co., Ltd (labeler code 87370) lists 26 products in the FDA National Drug Code Directory. By type: 26 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 1, 2026.

The request: Watch El-Peptido (Shanghai) Biopharmaceutical Co., Ltd (FDA labeler code 87370): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
87370
Products in commercial distribution
26
Packages
202
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
12
Earliest marketing start
February 5, 2020
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding26100%

Products by type

TypeProductsShare
Bulk ingredients26100%

Dosage forms

Dosage formProductsShare
Powder26100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Vasoactive intestinal peptide (vip) acetate87370-034PowderBulk ingredients for compoundingOctober 1, 2026
Elamipretide acetate87370-135PowderBulk ingredients for compoundingJuly 8, 2026
Ipamorelin acetate87370-011PowderBulk ingredients for compoundingJanuary 12, 2026
Mitochondria-derived peptide mots-c87370-010PowderBulk ingredients for compoundingJanuary 12, 2026
Thymosin beta-4 acetate87370-009PowderBulk ingredients for compoundingJanuary 12, 2026
Tirzepatide87370-008PowderBulk ingredients for compoundingJanuary 12, 2026
Tesamorelin acetate87370-007PowderBulk ingredients for compoundingJanuary 12, 2026
Sermorelin acetate87370-006PowderBulk ingredients for compoundingJanuary 12, 2026
Semaglutide87370-005PowderBulk ingredients for compoundingJanuary 12, 2026
Cjc-1295 acetate87370-003PowderBulk ingredients for compoundingJanuary 12, 2026
Bpc-157 acetate87370-002PowderBulk ingredients for compoundingJanuary 12, 2026
Aod 9604 acetate87370-001PowderBulk ingredients for compoundingJanuary 12, 2026
Dihexa acetate87370-032PowderBulk ingredients for compoundingFebruary 5, 2020
Copper peptide(ghk-cu)87370-031PowderBulk ingredients for compoundingFebruary 5, 2020
Gonadorelin acetate87370-028PowderBulk ingredients for compoundingFebruary 5, 2020
Epitalon acetate87370-027PowderBulk ingredients for compoundingFebruary 5, 2020
Dsip acetate87370-026PowderBulk ingredients for compoundingFebruary 5, 2020
Kpv87370-023PowderBulk ingredients for compoundingFebruary 5, 2020
Bremelanotide acetate87370-022PowderBulk ingredients for compoundingFebruary 5, 2020
Ghrp-287370-021PowderBulk ingredients for compoundingFebruary 5, 2020
Melanotan ii87370-019PowderBulk ingredients for compoundingFebruary 5, 2020
Oxytocin87370-018PowderBulk ingredients for compoundingFebruary 5, 2020
Tb-50087370-017PowderBulk ingredients for compoundingFebruary 5, 2020
Semax acetate87370-014PowderBulk ingredients for compoundingFebruary 5, 2020
Selank acetate87370-013PowderBulk ingredients for compoundingFebruary 5, 2020

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.